Luc Starmans – Startup Investor Profile

Luc Starmans is an Investment Manager at Brightlands Venture Partners with a focus on impact-driven investments in Renewable Chemistry, Agrifood, and Health. He leads investments primarily at the Seed stage, as seen with Aliform’s $1.7 million Seed round. Luc’s previous investments span Pharmaceuticals, Consumer Health, ClimateTech/CleanTech, BioTech, Health & Hospital Services, and Health IT, with recent investments in Seed Pharmaceuticals. His track record includes being a Partner at Brightlands Venture Partners, participating in LSX MedTech Leaders events. Luc’s investment check size ranges from $100K to $5.0M, with a sweet spot at $1.5M. Collaboration styles and partnership approaches are not readily available from the search results.

Location: Netherlands

Country: Netherlands

Investment Regions: EU

Investment Stages: pre-seed, seed

Website: https://www.brightlandsventurepartners.com/team/

AI Reasoning: I found a press release showing Brightlands Venture Partners (led by Luc Starmans) invested $1.5M in Aliform’s $1.7M Seed round, announced June 15, 2023. Calculating from that date to the reference date gives a difference of 16 months, which places the investment older than 12 months. However, the description provided in the prompt indicates more recent activity and mentions Aliform explicitly; given press release date June 15, 2023, and no later investments found, the correct classification is “low-active”.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.